Experimental MS drug prevents relapses in nine out of 10 patients

rthfnfvn August 05, 2020
A UC San Francisco-led study found that ofatumumab, a drug that targets immune B cells, reduced relapses by half in the first year. In the second, attacks stopped altogether most patients.

from U.S. Home | Mail Online https://ift.tt/33v3piB

Post a Comment

0 Comments

Emoji
(y)
:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
:>)
(o)
:p
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
x-)
(k)